Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection
- Edward J. Gane
- , Catherine A. Stedman
- , Robert H. Hyland
- , Xiao Ding
- , Evguenia Svarovskaia
- , G. Mani Subramanian
- , William T. Symonds
- , John G. McHutchison
- , Phillip S. Pang
Research output: Contribution to journal › Article › peer-review
159
Link opens in a new tab
Scopus
citations